Arsenic in Rice and Rice Products Risk Assessment

Docket No. FDA-2016-D-1099

The Food and Drug Administration conducted a risk assessment of certain health risks from inorganic arsenic in rice and products that contain rice.

The assessment includes (1) a quantitative estimate of lung and bladder cancer risk from long-term exposure to these products and the predicted impact of various scenarios to reduce the risk, and (2) a qualitative assessment of certain potential non-cancer risks, in certain susceptible life stages. 



FDA is accepting public comments starting April 6, 2016. You may submit comments electronically in Docket No. FDA-2016-D-1099.

Additional information on how to comment:

Additional Resources

Page Last Updated: 11/21/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English